Overview

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate 3 test formulations relative to a reference formulation.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Bazedoxifene
Estrogens
Estrogens, Conjugated (USP)